The MetroHealth System — Cleveland, Ohio

The MetroHealth System is a clinical research site located in Cleveland, Ohio, United States 44109.

Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

The MetroHealth System has participated in 27 clinical trials with 11 currently active.

Therapeutic areas: ACE Inhibitor Induced Angioedema, Gastroesophageal Reflux Disease (GERD), Reflux, Gastroesophageal.

Sponsors: Shire, EndoStim Inc., University of Alabama at Birmingham.

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The MetroHealth System?

The MetroHealth System has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The MetroHealth System conducted?

The MetroHealth System has 27 clinical trials on record, with 11 currently active. Their work covers ACE Inhibitor Induced Angioedema, Gastroesophageal Reflux Disease (GERD), Reflux, Gastroesophageal.

Is The MetroHealth System accredited by Crixeo Health?

Yes — The MetroHealth System holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about The MetroHealth System?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.